Careers Media center Contacts

MEPENAM




Active substance: meropenem

ATC: J01D H02

How supplied: Powder for injection

Dosage form
Powder for injection intravenous adm. №1.

Active ingredient
1 vial contains meropenem trihydrate, equivalent to 1.0 g of meropenem.

Indications
Treatment of infections caused by meropenem-susceptible bacteria: pneumonia, including nosocomial pneumonia; urinary tract infection; intra-abdominal infection; gynecological infections such as endometritis; infection of skin and soft tissues; meningitis; septicemia; empirical treatment for suspected bacterial infection in adults with febrile neutropenia, as a monotherapy or in combination with antiviral or antifungal drugs.
Mepenam is used as a monotherapy or in combination with other antimicrobial agents for the treatment of polymicrobial infections (such as cystic fibrosis, chronic lower respiratory tract infections).

 

ATTENTION!

The following information is intended for medical and pharmaceutical professionals only and can be used exclusively in professional activities.

ARE YOU A MEDICAL AND/OR PHARMACEUTICAL PROFESSIONAL?

(submitting the answer, you bear full responsibility for the accuracy of the information provided)


The presented package image matches the product design registered with the Ukrainian regulatory authorities.

If you have noticed any differences, please call us at +380 44 490 75 22

PHARMACOVIGILANCE

If you have information about any adverse effects or other drug-related problems, please fill in the form